Can progestin be limited to every third month only in postmenopausal women taking estrogen?-Reference-Cited by-同舟云学术

Can progestin be limited to every third month only in postmenopausal women taking estrogen?

Published:1995-01 Issue:1 Volume:21 Page:39-44
ISSN:0378-5122
Container-title:Maturitas
language:en
Short-container-title:Maturitas

Author:

Hirvonen Erkki,Salmi Tuula,Puolakka Jukka,Heikkinen Jorma,Granfors Elina,Hulkko Seppo,Mäkäräinen Leo,Nummi Simo,Pekonen Fredrika,Rautio Anna-Maija,Sundström Helena,Telimaa Sakari,Wilen-Rosenqvist Gunilla,Virkkunen Anja,Wahlström Torsten

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,General Biochemistry, Genetics and Molecular Biology

Reference11 articles.

1. Compliance considerations with estrogen replacement: Withdrawal bleeding and other factors;Hahn;Am J Obstet Gynecol,1989

2. Role of estrogen and progesterone in the etiology and prevention of endometrial cancer;Gambrell;Am J Obstet Gynecol,1983

3. Risk of ĕndometrial cancer after treatment with estrogen alone or in conjunction with progestogens: results of a prospective study;Persson;Br Med J,1989

4. Re-evaluating the role of progestogen therapy after the menopause;Henderson;Fertil Steril,1988

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Perimenopausal Transdermal Estradiol and Micronized Progesterone on Markers of Risk for Arterial Disease;The Journal of Clinical Endocrinology & Metabolism;2019-12-15

2. Sexual Function Under Adequate Estrogen Therapy in Women After Oophorectomy Versus Natural Menopause;Journal of Women's Health;2019-08

3. Hormone replacement therapy after risk reducing salpingo-oophorectomy in patients with BRCA1 or BRCA2 mutations; a systematic review of risks and benefits;Gynecologic Oncology;2019-04

4. Evaluation of gonadotropin-releasing hormone agonist treatment for prevention of menstrual-related attacks in acute porphyria;Acta Obstetricia et Gynecologica Scandinavica;2010-01

5. Endometrial safety and bleeding pattern during a five-year treatment with long-cycle hormone therapy;Menopause;2005-11